comprehensive -WSS

comprehensive

author：hotspot 2025-09-27 19:28:19 - browse：72

In this photo illustration, Farxiga, Xarelto, Entresto, and Eliquis are made available to customers at the New City Halsted Pharmacy on August 29, 2023 in Chicago, Illinois. These are 4 of 10 prescription drugs that will be subject to Medicare price negotiations under the Inflation Reduction Act. The other drugs include Jardiance, Enbrel, Januvia, Imbruvica, Stelara and Fiasp. — Scott Olson/Getty Images

WASHINGTON — The Biden administration is making its opening offers to pharmaceutical companies in its brand-new Medicare drug price negotiation program on Thursday, administration officials said. And that’s about all they said.

The offers will not be made public unless a manufacturer chooses to publicly disclose information about the talks, a senior administration official said. Companies have until March 2 to either accept the government’s offer or propose a counteroffer. The Biden administration will publish the final prices by Sept. 1 of this year after the negotiation process ends.

The negotiated prices won’t take effect until 2026.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： HCA discloses massive data breach affecting 11 million patients

Wikipedia

WSS

Hospital price transparency does save money, advocate argues

Threats against the LGBTQIA+ community intensifying: Department of Homeland Security

FDA warns J&J's Abiomed: We will regulate your software

STAT Summit: How a Chicago ER doctor tackles gun violence

Beam Therapeutics to lay off 20% of its staff, re

FDA gives detailed accounting of AI

explore

comprehensive

hotspot

In age of alternative facts, a scholarly course on calling out crap

Why health workers in Gaza are injured or die at high rates

Walensky prepares to leave CDC — and Congress — behind

STAT Summit: GSK CEO on pharma giant's new direction

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Iowa House, Senate pass 6

The cancer drug shortage isn’t new — and neither are the solutions

NIH fellows want a pay raise. Will that mean less money for grants?

What does generative AI mean for health care? We asked experts

Studies point to risks of excluding people with obesity from drug trials

Wikipedia

NIH fellows want a pay raise. Will that mean less money for grants?

Racing yachts have close encounter with pod of orcas near Strait of Gibraltar

CEOs share strategies for surviving biotech slump

CEOs share strategies for surviving biotech slump

Bulgari apologizes to China for listing Taiwan as a country after online backlash

NIH fellows want a pay raise. Will that mean less money for grants?

Wikipedia

hotspot

entertainment

leisure time